Boston Scientific Corporation (BSX): Price and Financial Metrics
Boston Scientific Corporation (BSX)
Today's Latest Price: $37.78 USD
Updated Jun 2 1:21pm
Add BSX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 132 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
BSX Stock Summary
- With a market capitalization of $52,475,629,575, Boston Scientific Corp has a greater market value than 96.5% of US stocks.
- Price to trailing twelve month operating cash flow for BSX is currently 37.24, higher than 91.06% of US stocks with positive operating cash flow.
- The volatility of Boston Scientific Corp's share price is greater than that of just 15.47% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to Boston Scientific Corp are BAX, ATVI, EW, ABB, and ZTS.
- Visit BSX's SEC page to see the company's official filings. To visit the company's web site, go to www.bostonscientific.com.
BSX Stock Price Chart More Charts
BSX Price/Volume Stats
| Current price | $37.78 | 52-week high | $46.62 |
| Prev. close | $37.50 | 52-week low | $24.10 |
| Day low | $37.48 | Volume | 4,187,840 |
| Day high | $37.93 | Avg. volume | 11,195,288 |
| 50-day MA | $35.08 | Dividend yield | N/A |
| 200-day MA | $39.77 | Market Cap | 52.87B |
Boston Scientific Corporation (BSX) Company Bio
Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. The company was founded in 1979 and is based in Marlborough, Massachusetts.
BSX Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $37.78 | $6.64 | -83% |
We started the process of determining a valid price forecast for Boston Scientific Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Boston Scientific Corp ranked in the 15th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for BSX, they are:
- Boston Scientific Corp's effective tax rate, as measured by taxes paid relative to net income, is at 121 -- greater than 97.6% of US stocks with positive free cash flow.
- The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than 60.79% of stocks in its sector (Healthcare).
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -83% |
| 1% | -83% |
| 2% | -83% |
| 3% | -82% |
| 4% | -82% |
| 5% | -82% |
Want more companies with a valuation profile/forecast similar to that of Boston Scientific Corp? See TECH, A, EW, QGEN, and TFX.
Loading social stream, please wait...